A European-African partnership aimed at improving the ethics and regulatory capacity of clinical research in Central African countries has successfully proposed its project (AfriHetique) to the European Commission (EDCTP). The partnership is coordinated by CANTAM, the Network of Excellence in clinical research for Central African region, lead by Prof. Francine Ntoumi.
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including
Pregnant women, babies and children under 5 years of age are the most vulnerable to malaria. In 2018, around 11 million pregnant women and 24 million children got malaria. Furthermore,
In Africa, pregnant women and young children are the most vulnerable to malaria. However, malaria control interventions and strategies have achivied important results in the last years. COVID-19 has now